NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care
First Annual Meeting
Thursday, June 12
The agenda will be updated as information becomes available.
8:30 AM
Light Breakfast
9:30 AM
Welcome and Consortium Overview
9:45 AM
Keynote: The Caregiving Challenges to Individuals and Families Dealing with Alzheimer’s Disease and Related Dementias
Courtney Van Houtven
Duke University School of Medicine | Duke-Margolis Institute for Health Policy
10:30 AM
Coffee Break
10:45 AM
Research Panel 1: The Economics of Caregiving for People Living with Alzheimer’s Disease
Moderator: Kathleen McGarry
Long-Term Care in the United States and Around the World
Gopi Shah Goda, Brookings Institution
Family Spillovers of ADRD
Yulya Truskinovsky, Syracuse University
The Effects of Minimum Wage and Overtime Protection on Labor Force Stability in a Labor-Intensive and Regulated Labor Market: The Case of the Home Health Care Industry
Kate Miller, Johns Hopkins University
12:00 PM
Lunch
1:00 PM
Research Panel 2: The Economics of Medical Care for People with Alzheimer’s Disease
Moderator: Julie Bynum
How Do Surrogates Make Treatment Decisions for Patients with Dementia? An Experimental Survey Study
Lauren Nicholas, University of Colorado
Impact of Institutional Special Needs Plans on Hospitalization Rates for Nursing Home Residents with Dementia
Cyrus Kosar, Brown University
Telemedicine: A Substitute or Complement for Home-Based Medical Care? The Experience of Medicare Enrollees with Alzheimer’s Disease and Related Dementias
Amresh Hanchate, Wake Forest University
2:15 PM
Coffee Break
2:30 PM
Research Panel 3: Early Detection and Classification of Dementia Symptoms
Moderator: Rhoda Au
Disparities in the Accuracy of Dementia Classifications in Medicare Fee-for-Service and Medicare Advantage Data
Peter Hudomiet, RAND Corporation
Experience with Implementing Cognitive Testing and Blood-Based Ad Biomarkers in Primary Care Practices
Michelle Mielke, Wake Forest University
3:45 PM
Keynote: Opportunities for Study and Insight in the Economics of Alzheimer’s Disease